Market Cap

$579.3M

Volume

2.9M

Cash and Equivalents

$88.2M

EBITDA

$97.4M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$253.0M

Profit Margin

66.86%

52 Week High

$15.70

52 Week Low

$3.26

Dividend

N/A

Price / Book Value

-1.86

Price / Earnings

-201.13

Price / Tangible Book Value

-1.84

Enterprise Value

$1.1B

Enterprise Value / EBITDA

10.91

Operating Income

$95.4M

Return on Equity

0.98%

Return on Assets

13.05

Cash and Short Term Investments

$88.2M

Debt

$614.9M

Equity

-$311.3M

Revenue

$378.4M

Unlevered FCF

$100.2M

Sector

Biotechnology

Category

N/A